## Affidea Embraces Digital Transformation with Roczen: A Personalized Solution for Obesity and Diabetes Management
Affidea, the leading pan-European provider of community-based healthcare, is making waves in the fight against obesity and type 2 diabetes. The company has announced a strategic collaboration with Reset Health, a digital health leader, to implement the Roczen platform across its network. This innovative solution offers a doctor-led, digitally-powered care model designed to effectively manage these chronic conditions.
Roczen: More Than Just a Digital Platform
Roczen is more than just a digital platform; it’s a comprehensive approach to managing obesity and type 2 diabetes. It leverages data-driven insights and evidence-based interventions to create personalized treatment plans for each patient.
Key Features of Roczen:
*
Continuous Monitoring:
Roczen tracks vital health metrics, allowing healthcare providers to intervene promptly when needed.*
Personalized Plans:
The platform creates bespoke treatment plans based on real-time patient data and individual needs.*
Enhanced Communication:
Patients can communicate directly with their healthcare providers, ensuring seamless management and ongoing support.*
Sustainable Lifestyle Changes:
Roczen emphasizes sustainable behavior changes, including dietary modifications, physical activity, and mental health support.*
GLP-1 Medications:
The platform provides access to GLP-1 medications for qualified patients, offering a comprehensive approach to chronic disease management.A Collaboration for Enhanced Patient Care
Affidea’s collaboration with Reset Health aligns perfectly with its mission to deliver innovative and patient-focused care pathways. By integrating digital therapeutics with professional healthcare support, Affidea aims to provide personalized, accessible, and affordable care to help patients manage their health effectively.
Addressing a Growing Health Challenge
The partnership comes at a crucial time as the prevalence of obesity and type 2 diabetes continues to rise in Europe. According to the World Health Organization (WHO), nearly 60% of adults in Europe are overweight, and 23% are classified as obese. This trend is projected to worsen, with obesity rates expected to increase by 10-15% by 2030.
Empowering Patients to Take Control
Dr. Charles Niehaus, Executive Director of Affidea Group, highlights the platform’s potential: “At Affidea, we are dedicated to providing the highest quality of care tailored to individual needs. Roczen allows us to offer a clinically validated approach to weight management and diabetes care, empowering our patients to take control of their health and improve their quality of life.”
Dr. David Wong, Chairman at Reset Health, shares the company’s commitment to supporting patients: “We are excited to partner with Affidea to deliver high-quality, clinically-proven weight management and diabetes care across Europe. By providing access to Roczen, we will support people living with obesity and type 2 diabetes to have individualised care that is tailored to their needs.”
The Future of Obesity and Diabetes Management
The introduction of Roczen marks a significant step in the evolution of obesity and diabetes management. By combining advanced technology, personalized care, and professional expertise, Affidea and Reset Health are paving the way for a healthier future for millions of individuals across Europe.
